Free Trial
NASDAQ:CRON

Cronos Group (CRON) Stock Price, News & Analysis

Cronos Group logo
$2.09 -0.01 (-0.48%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$2.09 0.00 (0.00%)
As of 07/11/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cronos Group Stock (NASDAQ:CRON)

Key Stats

Today's Range
$2.08
$2.13
50-Day Range
$1.85
$2.14
52-Week Range
$1.60
$2.54
Volume
1.14 million shs
Average Volume
1.36 million shs
Market Capitalization
$806.08 million
P/E Ratio
16.08
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cronos Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
31st Percentile Overall Score

CRON MarketRank™: 

Cronos Group scored higher than 31% of companies evaluated by MarketBeat, and ranked 790th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Cronos Group.

  • Earnings Growth

    Earnings for Cronos Group are expected to grow in the coming year, from ($0.03) to $0.03 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cronos Group is 16.08, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.86.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cronos Group is 16.08, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.26.

  • Price to Book Value per Share Ratio

    Cronos Group has a P/B Ratio of 0.72. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Cronos Group's valuation and earnings.
  • Percentage of Shares Shorted

    1.43% of the float of Cronos Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Cronos Group has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cronos Group has recently decreased by 1.38%, indicating that investor sentiment is improving.
  • Dividend Yield

    Cronos Group does not currently pay a dividend.

  • Dividend Growth

    Cronos Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.43% of the float of Cronos Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Cronos Group has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cronos Group has recently decreased by 1.38%, indicating that investor sentiment is improving.
  • News Sentiment

    Cronos Group has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Cronos Group this week, compared to 2 articles on an average week.
  • Search Interest

    Only 5 people have searched for CRON on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    Only 4 people have added Cronos Group to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cronos Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.30% of the stock of Cronos Group is held by insiders.

  • Percentage Held by Institutions

    Only 8.71% of the stock of Cronos Group is held by institutions.

  • Read more about Cronos Group's insider trading history.
Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Stock News Headlines

[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
See More Headlines

CRON Stock Analysis - Frequently Asked Questions

Cronos Group's stock was trading at $2.02 on January 1st, 2025. Since then, CRON shares have increased by 3.5% and is now trading at $2.09.

Cronos Group Inc. (NASDAQ:CRON) posted its quarterly earnings data on Thursday, May, 8th. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.01. The business earned $33.62 million during the quarter, compared to the consensus estimate of $45.44 million. Cronos Group had a negative trailing twelve-month return on equity of 0.07% and a net margin of 39.69%.
Read the conference call transcript
.

Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cronos Group investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
5/08/2025
Today
7/13/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CRON
CIK
1656472
Fax
N/A
Employees
450
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.13
Trailing P/E Ratio
16.08
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$41.08 million
Net Margins
39.69%
Pretax Margin
37.64%
Return on Equity
-0.07%
Return on Assets
-0.07%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
27.80
Quick Ratio
26.75

Sales & Book Value

Annual Sales
$124.59 million
Price / Sales
6.47
Cash Flow
$0.00 per share
Price / Cash Flow
4,491.53
Book Value
$2.90 per share
Price / Book
0.72

Miscellaneous

Outstanding Shares
385,682,000
Free Float
357,527,000
Market Cap
$806.08 million
Optionable
Optionable
Beta
1.03
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:CRON) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners